Exploring Marine Resources for Bioactive Compounds

 

 Permissions and Reprints

Abstract

Biodiversity in the seas is only partly explored, although marine organisms are excellent sources for many industrial products. Through close co-operation between industrial and academic partners, it is possible to successfully collect, isolate and classify marine organisms, such as bacteria, fungi, micro- and macroalgae, cyanobacteria, and marine invertebrates from the oceans and seas globally. Extracts and purified compounds of these organisms can be studied for several therapeutically and industrially significant biological activities, including anticancer, anti-inflammatory, antiviral, antibacterial, and anticoagulant activities by applying a wide variety of screening tools, as well as for ion channel/receptor modulation and plant growth regulation. Chromatographic isolation of bioactive compounds will be followed by structural determination. Sustainable cultivation methods for promising organisms and biotechnological processes for selected compounds can be developed, as well as biosensors for monitoring the target compounds. The (semi)synthetic modification of marine-based bioactive compounds produces their new derivatives, structural analogs and mimetics that could serve as hit or lead compounds and be used to expand compound libraries based on marine natural products. The research innovations can be targeted for industrial product development in order to improve the growth and productivity of marine biotechnology. Marine research aims at a better understanding of environmentally conscious sourcing of marine biotechnology products and increased public awareness of marine biodiversity. Marine research is expected to offer novel marine-based lead compounds for industries and strengthen their product portfolios related to pharmaceutical, nutraceutical, cosmetic, agrochemical, food processing, material and biosensor applications.

• References

• 1 Blunt JW, Munro MHG. Dictionary of marine natural products. Boca Raton: Chapmann & Hall/CRC; 2007. (Available at http://dmnp.chemnetbase.com/intro/index.jsp. Accessed July 2, 2014.)
  Google Scholar
• 2 Mora C, Tittensor DP, Adl S, Simpson AGB, Worm B. How many species are there on Earth and in the ocean?. PLoS Biol 2011; 9: e1001127
  CrossrefPubMedGoogle Scholar
• 3 Sennet SH. Marine chemical ecology: applications in marine biomedical prospecting. In: McClintock JB, Baker BJ, editors Marine chemical ecology. Boca Raton: CRC Press; 2001: 523-542
  CrossrefGoogle Scholar
• 4 Blunt JW, Copp BR, Keyzers RA, Munro MHG, Prinsep MR. Marine natural products. Nat Prod Rep 2014; 31: 160-258
  CrossrefPubMedGoogle Scholar
• 5 Blunt JW, Copp BR, Keyzers RA, Munro MHG, Prinsep MR. Marine natural products. Nat Prod Rep 2013; 30: 237-323
  CrossrefPubMedGoogle Scholar
• 6 Cragg GM, Newman DJ. Natural products: a continuing source of novel drug leads. Biochim Biophys Acta 2013; 1830: 3670-3695
  CrossrefPubMedGoogle Scholar
• 7 Mayer AM, Glaser KB, Cuevas C, Jacobs RS, Kem W, Little RD, McIntosh JM, Newman DJ, Potts BC, Shuster DE. The odyssey of marine pharmaceuticals: a current pipeline perspective. Trends Pharmacol Sci 2010; 31: 255-265
  CrossrefPubMedGoogle Scholar
• 8 Cuevas C, Pérez M, Martín MJ, Chicharro JL, Fernández-Rivas C, Flores M, Francesch A, Gallego P, Zarzuelo M, de La Calle F, García J, Polanco C, Rodríguez I, Manzanares I. Synthesis of ecteinascidin ET–743 and phthalascidin Pt–650 from cyanosafracin B. Org Lett 2000; 2: 2545-2548
  CrossrefPubMedGoogle Scholar
• 9 Kem W, Soti F, Wildeboer K, LeFrancois S, MacDougall K, Wei DQ, Chou KC, Arias HR. The nemertine toxin anabaseine and its derivative DMXBA (GTS–21): chemical and pharmacological properties. Mar Drugs 2006; 4: 255-273
  CrossrefPubMedGoogle Scholar
• 10 Molinski TF, Dalisay DS, Lievens SL, Saludes JP. Drug development from marine natural products. Nat Rev Drug Discov 2009; 8: 69-85
  CrossrefPubMedGoogle Scholar
• 11 Coll M, Carreras M, Ciercoles C, Cornax MJ, Gorelli G, Morote E, Saez R. Assessing fishing and marine biodiversity changes using fishersʼ perceptions: the Spanish Mediterranean and Gulf of Cadiz case study. PLoS One 2014; 9: e85670/1-e85670/15
  PubMedGoogle Scholar
• 12 Cragg GM, Katz F, Newman DJ, Rosenthal J. Legal and ethical issues involving marine biodiscovery and development. In: Fattorusso E, Gerwick WH, Taglialatela-Scafati O, editors Handbook of marine natural products. Dordrecht: Springer; 2012: 1314-1342
  CrossrefGoogle Scholar
• 13 Gareth RJ, Jennifer MG. The experience and evolution of trust: implications for cooperation and teamwork. Acad Manage Rev 1998; 23: 531-546
  PubMedGoogle Scholar
• 14 Kornprobst JM. Encyclopedia of marine natural products, Volume 1. Weinheim: Wiley-Blackwell; 2010: 43-169 447
  Google Scholar
• 15 Rothschild LJ, Mancinelli RL. Life in extreme environments. Nature 2001; 409: 1092-1101
  CrossrefPubMedGoogle Scholar
• 16 Thomas TRA, Kavlekar DP, LokaBharathi PA. Marine drugs from sponge-microbe association–A review. Mar Drugs 2010; 8: 1417-1468
  CrossrefPubMedGoogle Scholar
• 17 Felczykowska A, Bloch SK, Nejman-Faleńczyk B, Barańska S. Metagenomic approach in the investigation of new bioactive compounds in the marine environment. Acta Biochim Pol 2012; 59: 501-505
  PubMedGoogle Scholar
• 18 Butler MS, Blaskovich MA, Cooper MA. Antibiotics in the clinical pipeline in 2013. J Antibiot 2013; 66: 571-591
  CrossrefPubMedGoogle Scholar
• 19 Jang KH, Nam SJ, Locke JB, Kauffman CA, Beatty DS, Paul LA, Fenical W. Anthracimycin, a potent anthrax antibiotic from a marine-derived actinomycete. Angew Chem Int Ed 2013; 52: 7822-7824
  CrossrefPubMedGoogle Scholar
• 20 Mahajan G, Thomas B, Parab R, Patel ZE, Kuldharan S, Yemparala V, Mishra PD, Ranadive P, DʼSouza L, Pari K, Girish HS. In vitro and in vivo activities of antibiotic PM181104. Antimicrob Agents Chemother 2013; 57: 5315-5319
  CrossrefPubMedGoogle Scholar
• 21 Singh S, Kate BN, Banerjee UC. Bioactive compounds from cyanobacteria and microalgae: an overview. Crit Rev Biotechnol 2005; 25: 73-95
  CrossrefPubMedGoogle Scholar
• 22 Burja AM, Banaigs B, Abou-Mansourc E, Burgess JG, Wright PC. Marine cyanobacteria–a prolific source of natural products. Tetrahedron 2001; 57: 9347-9377
  CrossrefPubMedGoogle Scholar
• 23 Welker M, von Döhren H. Cyanobacterial peptides – natureʼs own combinatorial biosynthesis. FEMS Microbiol Rev 2006; 30: 530-563
  CrossrefPubMedGoogle Scholar
• 24 Cohen Z, Margheri MC, Tomaselli L. Chemotaxonomy of cyanobacteria. Phytochemistry 1995; 40: 1155-1158
  CrossrefPubMedGoogle Scholar
• 25 Welker M, Brunke M, Preussel K, Lippert I, von Döhren H. Diversity and distribution of Microcystis (Cyanobacteria) oligopeptide chemotypes from natural communities studied by single–colony mass spectrometry. Microbiology 2004; 150: 1785-1796
  CrossrefPubMedGoogle Scholar
• 26 Welker M, Christiansen G, von Döhren H. Diversity of coexisting Planktothrix (Cyanobacteria) chemotypes deduced by mass spectral analysis of microystins and other oligopeptides. Arch Microbiol 2004; 182: 288-298
  CrossrefPubMedGoogle Scholar
• 27 Diehnelt CW, Dugan NR, Peterman SM, Budde WL. Identification of microcystin toxins from a strain of Microcystis aeruginosa by liquid chromatography introduction into a hybrid linear ion trap – Fourier transform ion cyclotron resonance mass spectrometer. Anal Chem 2006; 78: 501-512
  CrossrefPubMedGoogle Scholar
• 28 Walker M, Erhard M. Consistency between chemotyping of single filaments of Planktothrix rubescens (Cyanobacteria) by MALDI–TOF and the peptide patterns of strains determined by HPLC–MS. J Mass Spectrom 2007; 42: 1062-1068
  CrossrefPubMedGoogle Scholar
• 29 Shimizu Y. Microalgal metabolites. Chem Rev 1993; 93: 1685-1698
  CrossrefPubMedGoogle Scholar
• 30 Daranas AH, Norte M, Fernández JJ. Toxic marine microalgae. Toxicon 2001; 39: 1101-1132
  CrossrefPubMedGoogle Scholar
• 31 Nicolaou KC, Aversa RJ. Maitotoxin: an inspiration for synthesis. Isr J Chem 2011; 51: 359-377
  CrossrefPubMedGoogle Scholar
• 32 Matsubara K. Recent advances in marine algal anticoagulants. Curr Med Chem Cardiovasc Hematol Agents 2004; 2: 13-19
  CrossrefPubMedGoogle Scholar
• 33 Ekanayake PM, Nikapitiya C, De Zoysa M, Whang I, Kim SJ, Lee J. Novel anticoagulant compound from fermented red alga Pachymeniopsis elliptica . Eur Food Res Technol 2008; 227: 897-903
  CrossrefPubMedGoogle Scholar
• 34 Pushpamali WA, Nikapitiya C, De Zoysa M, Whang I, Kim SJ, Lee J. Isolation and purification of an anticoagulant from fermented red seaweed Lomentaria catenata . Carbohydr Polym 2008; 73: 274-279
  CrossrefPubMedGoogle Scholar
• 35 de Nys R, Steinberg PD. Linking marine biology and biotechnology. Curr Opin Biotechnol 2002; 13: 244-248
  CrossrefPubMedGoogle Scholar
• 36 Duarte K, Rocha-Santos TAP, Freitas AC, Duarte AC. Analytical techniques for discovery of bioactive compounds from marine fungi. Trends Anal Chem 2012; 34: 97-110
  CrossrefPubMedGoogle Scholar
• 37 Bergmann W, Feeney RJ. Contributions to the study of marine products. XXXII. The nucleosides of sponges I. J Org Chem 1951; 16: 981-987
  CrossrefPubMedGoogle Scholar
• 38 Lemaire P. Evolutionary crossroads in developmental biology: the tunicates. Development 2011; 138: 2143-2152
  CrossrefPubMedGoogle Scholar
• 39 Lewis RJ, Garcia ML. Therapeutic potential of venom peptides. Nat Rev Drug Discov 2003; 2: 790-802
  CrossrefPubMedGoogle Scholar
• 40 Clark RJ, Jensen J, Nevin ST, Callaghan BP, Adams DJ, Craik DJ. The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew Chem Int Ed 2010; 49: 6545-6548
  CrossrefPubMedGoogle Scholar
• 41 Rocha J, Peixe L, Gomes NCM, Calado R. Cnidarians as a source of new marine bioactive compounds–an overview of the last decade and future steps for bioprospecting. Mar Drugs 2011; 9: 1860-1886
  CrossrefPubMedGoogle Scholar
• 42 Mackie GO. Whatʼs new in cnidarian biology?. Can J Zool 2002; 80: 1649-1653
  CrossrefPubMedGoogle Scholar
• 43 Nelson JS. Fishes of the world, 4th edition. Hoboken: John Wiley & Sons Inc; 2006: 2-5
  Google Scholar
• 44 Reddy LH, Couvreur P. Squalene: a natural triterpene for use in disease management and therapy. Adv Drug Deliv Rev 2009; 61: 1412-1426
  CrossrefPubMedGoogle Scholar
• 45 Nieto FR, Cobos EJ, Tejada MÁ, Sánchez-Fernández C, González-Cano R, Cendán CR. Tetrodotoxin (TTX) as a therapeutic agent for pain. Mar Drugs 2012; 10: 281-305
  CrossrefPubMedGoogle Scholar
• 46 Esteves-Ferreira AA, Correa DM, Carneiro APS, Rosa RM, Loterio R, Araujo WL. Comparative evaluation of different preservation methods for cyanobacterial strains. J Appl Phycol 2013; 25: 919-929
  CrossrefPubMedGoogle Scholar
• 47 Guillard RRL. Purification methods for microalgae. In: Andersen AR, editor Algal culturing techniques. China: Elsevier Academic Press; 2005: 117-132
  CrossrefGoogle Scholar
• 48 Bohlin L, Alsmark C, Goeransson U, Klum M, Weden C, Backlund A. In: Tringali C, editor. Bioactive compounds from natural sources. 2nd. edition. Boca Raton: CRC Press; 2012: 1-36
  Google Scholar
• 49 Eriksen NT. The technology of microalgal culturing. Biotechnol Lett 2008; 30: 1525-1536
  CrossrefPubMedGoogle Scholar
• 50 Schmidt RS. Heterotrophic high cell–density fed–batch cultures of the phycocyanin–producing red alga Galdieria sulphuraria . Biotechnol Bioengin 2005; 90: 77-84
  CrossrefPubMedGoogle Scholar
• 51 Kupchan SM, Britton RW, Ziegler MF, Sigel CW. Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysenterica . J Org Chem 1973; 38: 178-179
  CrossrefPubMedGoogle Scholar
• 52 Donia MS, Ruffner DE, Cao S, Schmidt EW. Accessing the hidden majority of marine natural products through metagenomics. Chembiochem 2011; 12: 1230-1236
  CrossrefPubMedGoogle Scholar
• 53 Breton RC, Reynolds WF. Using NMR to identify and characterize natural products. Nat Prod Rep 2013; 30: 501-524
  CrossrefPubMedGoogle Scholar
• 54 Ghitti M, Musco G, Spitaleri A. NMR and computational methods in the structural and dynamic characterization of ligand-receptor interactions. Adv Exp Med Biol 2014; 805: 271-304
  PubMedGoogle Scholar
• 55 Matsumori N, Kaneno D, Murata M, Nakamura H, Tachibana K. Stereochemical determination of acyclic structures based on carbon-proton spin-coupling constants. A method of configuration analysis for natural products. J Org Chem 1999; 64: 866-876
  CrossrefPubMedGoogle Scholar
• 56 Seco JM, Quiñoá E, Riguera R. The assignment of absolute configuration by NMR. Chem Rev 2004; 104: 17-117
  CrossrefPubMedGoogle Scholar
• 57 Lee JA, Berg EL. Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches. J Biomol Screen 2013; 18: 1143-1155
  CrossrefPubMedGoogle Scholar
• 58 Fishburn CS. Translational research: the changing landscape of drug discovery. Drug Discov Today 2013; 18: 487-494
  CrossrefPubMedGoogle Scholar
• 59 Lang PK, Yeow K, Nichols A, Sheer A. Cellular imaging in drug discovery. Nat Rev Drug Discov 2006; 5: 343-356
  CrossrefPubMedGoogle Scholar
• 60 Lee JA, Uhlik MT, Moxham CM, Tomandl D, Sall DJ. Modern phenotypic drug discovery is a viable, neoclassic pharma strategy. J Med Chem 2012; 55: 4527-4538
  CrossrefPubMedGoogle Scholar
• 61 Sams-Dodd F. Is poor research the cause of the declining productivity of the pharmaceutical industry? An industry in need of a paradigm shift. Drug Discov Today 2013; 18: 211-217
  CrossrefPubMedGoogle Scholar
• 62 Harvey AL. Natural products as a screening resource. Curr Opin Chem Biol 2007; 11: 480-484
  CrossrefPubMedGoogle Scholar
• 63 Bugni TS, Richards B, Bhoite L, Cimbora D, Harper MK, Ireland CM. Marine natural product libraries for high–throughput screening and rapid drug discovery. J Nat Prod 2008; 71: 1095-1098
  CrossrefPubMedGoogle Scholar
• 64 Tawfike AF, Viegelmann C, Edrada-Ebel R. Metabolomics and dereplication strategies in natural products. Methods Mol Biol 2013; 1055: 227-244
  PubMedGoogle Scholar
• 65 Larsen TO, Smedsgaard J, Nielsen KF, Hansen ME, Frisvad JC. Phenotypic taxonomy and metabolite profiling in microbial drug discovery. Nat Prod Rep 2005; 22: 672-695
  CrossrefPubMedGoogle Scholar
• 66 Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov 2005; 4: 206-220
  CrossrefPubMedGoogle Scholar
• 67 Florence GJ, Gardner NM, Ian Paterson I. Development of practical syntheses of the marine anticancer agents discodermolide and dictyostatin. Nat Prod Rep 2008; 25: 342-375
  CrossrefPubMedGoogle Scholar
• 68 Chen JC, Chen XC, Willot M, Zhu J. Asymmetric total syntheses of ecteinascidin 597 and ecteinascidin 583. Angew Chem Int Ed 2006; 45: 8028-8032
  CrossrefPubMedGoogle Scholar
• 69 Shang S, Tan DS. Advancing chemistry and biology through diversity–oriented synthesis of natural product–like libraries. Curr Opin Chem Biol 2005; 9: 248-258
  CrossrefPubMedGoogle Scholar
• 70 Mantovani A, Balkwill F. RalB signaling: a bridge between inflammation and cancer. Cell 2006; 127: 42-44
  CrossrefPubMedGoogle Scholar
• 71 Castellani P, Balza E, Rubartelli A. Inflammation, DAMPs, tumor development, and progression: a vicious circle orchestrated by redox signaling. Antioxid Redox Sign 2014; 20: 1086-1097
  CrossrefPubMedGoogle Scholar
• 72 Luo JL, Kamata H, Karin M. IKK/NF-κB signaling: balancing life and death – a new approach to cancer therapy. J Clin Invest 2005; 115: 2625-2632
  CrossrefPubMedGoogle Scholar
• 73 Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. Inhibition of NF-κB in cancer cells converts inflammation- induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression. Cancer Cell 2004; 3: 297-305
  PubMedGoogle Scholar
• 74 Karin M, Greten FR. NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 10: 749-759
  PubMedGoogle Scholar
• 75 Grienke U, Silke J, Tasdemir D. Bioactive compounds from marine mussels and their effects on human health. Food Chemistry 2014; 142: 48-60
  CrossrefPubMedGoogle Scholar
• 76 Kim JA, Kim SK. Bioactive peptides from marine sources as potential anti-inflammatory therapeutics. Curr Protein Pept Sci 2013; 14: 177-182
  CrossrefPubMedGoogle Scholar
• 77 Moczydlowski EG. The molecular mystique of tetrodotoxin. Toxicon 2013; 63: 165-183
  CrossrefPubMedGoogle Scholar
• 78 Greenberg EN. Ziconitide. J Pain Palliat Care Pharmacother 2011; 25: 380-381
  CrossrefPubMedGoogle Scholar
• 79 Adams DJ, Berecki G. Mechanisms of conotoxin inhibition of N-type (Cav2.2) calcium channels. Biochim Biophys Acta 2013; 1828: 1619-1628
  CrossrefPubMedGoogle Scholar
• 80 Kresse H, Belsey MJ, Rovin H. The antibacterial drugs market. Nat Rev Drug Discov 2007; 6: 19-20
  CrossrefPubMedGoogle Scholar
• 81 Weaver SC, Barrett A. Transmission cycles, host range, evolution and emergence of arboviral disease. Nat Rev Microbiol 2004; 2: 789-801
  CrossrefPubMedGoogle Scholar
• 82 Pialoux G, Gaüzère BA, Jauréguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 2007; 7: 319-327
  CrossrefPubMedGoogle Scholar
• 83 Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, Silvi G, Angelini P, Dottori M, Ciufolini MG, Majori GC, Cassone A. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007; 370: 1840-1846
  CrossrefPubMedGoogle Scholar
• 84 Brummer-Korvenkontio M, Vapalahti O, Kuusisto P, Saikku P, Manni T, Koskela P, Nygren T, Brummer-Korvenkontio H, Vaheri A. Epidemiology of Sindbis virus infections in Finland 1981–96: possible factors explaining a peculiar disease pattern. Epidemiol Infect 2002; 129: 335-345
  PubMedGoogle Scholar
• 85 Mayer AMS, Jacobson PB, Fenical W, Jacobs RS, Glaser KB. Pharmacological characterization of the pseudopterosins: novel anti-inflammatory natural products isolated from the Caribbean soft coral, Pseudopterogorgia elisabethae . Life Sci 1998; 62: PL401-PL407
  CrossrefPubMedGoogle Scholar
• 86 Castanaro J, Lasker HR. Effects of clipping on growth of colonies of the Caribbean gorgonian Pseudopterogorgia elisabethae . Invertebr Biol 2003; 122: 299-307
  PubMedGoogle Scholar
• 87 Moore A. Blooming prospects? Humans have eaten seaweed for millennia; now microalgae are to be served up in a variety of novel health supplements, medicaments and preparations. EMBO Rep 2001; 2: 462-464
  CrossrefPubMedGoogle Scholar
• 88 Zhu D, Niu J, Shen S, Wang G. An economic assessment of astaxanthin production by large scale cultivation of Haematococcus pluvialis . Biotechn Adv 2011; 29: 568-574
  CrossrefPubMedGoogle Scholar
• 89 Picot C, Nguyen TA, Roudot AC, Parent-Massin DA. Preliminary risk assessment of human exposure to phycotoxins in shellfish: a review. Hum Ecol Risk Assess 2011; 17: 328-366
  CrossrefPubMedGoogle Scholar
• 90 Vilarino N, Louzao MC, Fraga M, Rodriguez LP, Botana LM. Innovative detection methods for aquatic algal toxins and their presence in the food chain. Anal Bioanal Chem 2013; 405: 7719-7732
  CrossrefPubMedGoogle Scholar
• 91 Campbell K. Biosensor technology for marine toxin analysis. In: Botana LM, editor Seafood and freshwater toxins, pharmacology, physiology, and detection. 3rd edition. Boca Raton: CRC Press; 2014: 347-366
  CrossrefGoogle Scholar
• 92 Eggins BR. Chemical sensors and biosensors. New York: John Wiley & Sons Inc; 2002: 5-9
  Google Scholar
• 93 Huang PJJ, Khimji I, Liu J. Immobilization of fluorescent aptamer biosensors on magnetic microparticles and its potential application for ocean sensing. In: Tiquia-Arashiro SM, editor Molecular biological technologies for ocean sensing. Dearborn: Humana Press; 2012: 151-168
  CrossrefGoogle Scholar
• 94 Weigl BH, Bardell RL, Cabrera CR. Lab-on-a-chip for drug development. Adv Drug Deliv Rev 2003; 55: 349-377
  CrossrefPubMedGoogle Scholar
• 95 Erickson D, Li D. Integrated microfluidic devices. Anal Chim Acta 2004; 507: 11-26
  CrossrefPubMedGoogle Scholar
• 96 Marquette CA, Coulet PR, Blum LJ. Semi-automated membrane based chemiluminescent immunosensor for flow injection analysis of okadaic acid in mussels. Anal Chim Acta 1999; 398: 173-182
  CrossrefPubMedGoogle Scholar
• 97 Desmet C, Blum LJ, Marquette CA. Multiplex microarray ELISA versus classical ELISA, a comparison study of pollutant sensing for environmental analysis. Environ Sci Process Impacts 2013; 15: 1876-1882
  CrossrefPubMedGoogle Scholar
• 98 Yakes BJ, Prezioso SM, DeGrasse SL. Developing improved immunoassays for paralytic shellfish toxins: the need for multiple, superior antibodies. Talanta 2012; 99: 668-676
  CrossrefPubMedGoogle Scholar
• 99 Kulagina NV, Twiner MJ, Hess P, McMahon T, Satake M, Yasumoto T, Ramsdell JS, Doucette GJ, Ma W, OʼShaughnessy TJ. Detection of marine toxins, brevetoxin-3 and saxitoxin, in seawater using neuronal networks. Environ Sci Technol 2006; 40: 578-583
  CrossrefPubMedGoogle Scholar
• 100 Strik WA, Ördög V, Van Staden J, Jäger K. Cytokinin- and auxin-like activity in Cyanophyta and microalgae. J Appl Phycol 2002; 14: 215-221
  CrossrefPubMedGoogle Scholar
• 101 Karthikeyan N, Prasanna R, Nain L, Kaushik BD. Evaluating the potential of plant growth promoting cyanobacteria as inoculants for wheat. Eur J Soil Biol 2007; 43: 23-30
  CrossrefPubMedGoogle Scholar
• 102 Peuthert A, Chakrabarti S, Pflugmache S. Uptake of microcystins-LR and -LF (cyanobacterial toxins) in seedlings of several important agricultural plant species and the correlation with cellular damage (lipid peroxidation). Environ Toxicol 2007; 22: 436-442
  CrossrefPubMedGoogle Scholar
• 103 Zaccaro MC, Kato A, Zulpa G, Storni MM, Steyerthal N, Lobasso K, Stella AM. Bioactivity of Scytonema hofmanni (Cyanobacteria) in Lilium alexandrae in vitro propagation. Electr J Biotechnol 2006; 9: 210-214
  PubMedGoogle Scholar
• 104 Berry JP, Gantar M, Perez MH, Berry G, Noriega FG. Cyanobacterial toxins as allelochemicals with potential applications as algaecides, herbicides and insecticides. Mar Drugs 2008; 6: 117-146
  CrossrefPubMedGoogle Scholar
• 105 Hellio C, Tsoukatou M, Maréchal JP, Aldred N, Beaupoil C, Clare AS, Vagias C, Roussis V. Inhibitory effects of Mediterranean sponge extracts and metabolites on larval settlement of the barnacle Balanus amphitrite . Mar Biotechnol 2005; 7: 297-305
  CrossrefPubMedGoogle Scholar
• 106 Chelossi E, Mancini I, Sepčić K, Turk T, Faimali M. Comparative antibacterial activity of polymeric 3-alkylpyridinium salts isolated from the Mediterranean sponge Reniera sarai and their synthetic analogues. Biomol Engin 2006; 23: 317-323
  CrossrefPubMedGoogle Scholar
• 107 Sjoegren M, Johnson AL, Hedner E, Dahlstroem M, Goeransson U, Shirani H, Bergman J, Jonsson PR, Bohlin L. Antifouling activity of synthesized peptide analogs of the sponge metabolite barettin. Peptides 2006; 27: 2058-2064
  CrossrefPubMedGoogle Scholar
• 108 Sjoegren M, Dahlstroem M, Goeransson U, Jonsson P, Bohlin L. Recruitment in the field of Balanus improvisus and Mytilus edulis in response to the antifouling cyclopeptides barettin and 8,9-dihydrobarettin from the marine sponge Geodia barrette . Biofouling 2004; 20: 291-297
  CrossrefPubMedGoogle Scholar
• 109 Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nature Rev Microbiol 2004; 2: 95-108
  CrossrefPubMedGoogle Scholar
• 110 Lear G, Lewis GD. Microbial biofilms: current research and applications. Norfolk: Caister Academic Press; 2012: 1-228
  Google Scholar
• 111 Matz C, Webb JS, Schupp PJ, Phang SY, Penesyan A, Egan S, Steinberg P, Kjelleberg S. Marine biofilm bacteria evade eukaryotic predation by targeted chemical defense. PLoS One 2008; 3: 1-7
  PubMedGoogle Scholar
• 112 Matz C. Struggle, communication, cooperation. Biochemical interactions in marine biofilms. Chem Unserer Zeit 2009; 43: 160-167
  CrossrefPubMedGoogle Scholar
• 113 Skogman M, Vuorela P, Fallarero A. Combining biofilm matrix measurements with biomass and viability assays in susceptibility assessments of antimicrobials against Staphylococcus aureus biofilms. J Antibiot 2012; 65: 453-459
  CrossrefPubMedGoogle Scholar
• 114 Manner S, Skogman M, Goeres D, Vuorela P, Fallarero A. Systematic exploration of natural and synthetic flavonoids for inhibition of Staphylococcus aureus biofilms. Int J Mol Sci 2013; 14: 19434-19451
  CrossrefPubMedGoogle Scholar
• 115 Ausbacher D, Fallarero A, Määttänen A, Kujala J, Ström MB, Vuorela PM. Staphylococcus aureus biofilm susceptibility to small and potent β2,2-amino acid derivatives. Biofouling 2014; 30: 81-93
  CrossrefPubMedGoogle Scholar